IP Library Granted Patent US 8,980,589
Granted Patent B2
US 8,980,589 · App. 13/218,591 · Granted Mar 17, 2015

Mutant delta-9 elongases and their use in making polyunsaturated fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,980,589
App. No.
13/218,591
Granted
Mar 17, 2015
Kind
B2
Abstract

Mutant delta-9 elongases having the ability to convert linoleic acid [18:2, LA] to eicosadienoic acid [20:2, EDA] and/or α-linolenic [18:3, ALA] to eicosatrienoic acid [20:3, ETrA] are disclosed herein. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding mutant delta-9 elongases, along with a method of making long chain polyunsaturated fatty acids [“PUFAs”] using these mutant delta-9 elongases in oleaginous yeast are also disclosed.

Claims (20)

1. An isolated polynucleotide comprising:

a nucleotide sequence encoding a mutant polypeptide having delta-9 elongase activity, wherein said mutant polypeptide comprises an amino acid sequence that (i) is at least 95% identical with the amino acid sequence of SEQ ID NO:10, and (ii) comprises an amino acid at position 35 selected from the group consisting of glycine, phenylalanine and methionine.

2. The isolated polynucleotide of claim 1 , wherein the nucleotide sequence is selected from the group consisting of SEQ ID NO:28, SEQ ID NO:58, SEQ ID NO:61, SEQ ID NO:86, SEQ ID NO:95, SEQ ID NO:96, SEQ ID NO:97, SEQ ID NO:100, SEQ ID NO:103, SEQ ID NO:106 and SEQ ID NO:109.

3. The isolated polynucleotide of claim 1 , wherein the mutant polypeptide comprises an amino acid sequence selected from the group consisting of: SEQ ID NO:29, SEQ ID NO:59, SEQ ID NO:62, SEQ ID NO:87, SEQ ID NO:101, SEQ ID NO:104, SEQ ID NO:107 and SEQ ID NO:110.

4. The isolated polynucleotide of claim 3 , wherein the mutant polypeptide comprises the amino acid sequence set forth in SEQ ID NO:59.

5. A recombinant construct comprising the isolated polynucleotide of claim 1 , wherein said nucleotide sequence is operably linked to at least one regulatory sequence.

6. A transformed cell comprising the recombinant construct of claim 5 .

7. The transformed cell of claim 6 , wherein said cell is selected from the group consisting of: plants, bacteria, yeast, algae, euglenoids, stramenopiles, oomycetes and fungi.

8. The transformed cell of claim 7 , wherein the cell is an oleaginous yeast producing at least about 25% of its dry cell weight as oil.

9. The transformed cell of claim 8 , wherein the oleaginous yeast further comprises at least one recombinant DNA construct comprising an isolated polynucleotide operably linked to at least one regulatory sequence, the recombinant DNA construct encoding a polypeptide selected from the group consisting of: delta-4 desaturase, delta-5 desaturase, delta-8 desaturase, delta-6 desaturase, delta-9 desaturase, delta-12 desaturase, delta-15 desaturase, delta-17 desaturase, C 14/16 elongase, C 16/18 elongase, C 18/20 elongase and C 20/22 elongase.

10. The transformed cell of claim 9 , wherein oil produced by the oleaginous yeast comprises a long-chain polyunsaturated fatty acid selected from the group consisting of: arachidonic acid, eicosadienoic acid, eicosapentaenoic acid, eicosatetraenoic acid, eicosatrienoic acid, dihomo-gamma-linolenic acid, docosatetraenoic acid, docosapentaenoic acid and docosahexaenoic acid.

11. The transformed cell of claim 8 , wherein the oleaginous yeast is selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

12. The transformed cell of claim 11 , wherein the cell is a Yarrowia lipolytica.

13. A method for producing a polyunsaturated fatty acid comprising:

a) providing an oleaginous yeast comprising:

i) the recombinant construct of claim 5 , and

ii) a source of substrate fatty acid selected from the group consisting of linoleic acid and alpha-linolenic acid;

b) growing the yeast of step (a) under conditions wherein the mutant polypeptide having delta-9 elongase activity is expressed and the substrate fatty acid is converted to product fatty acid, wherein linoleic acid is converted to eicosadienoic acid and alpha-linolenic acid is converted to eicosatrienoic acid, and

c) optionally recovering the product fatty acid of step (b).

14. A recombinant microbial host cell producing an oil comprising at least 22.5 weight percent of eicosapentaenoic acid measured as a weight percent of dry cell weight, said recombinant microbial host cell comprising at least one mutant delta-9 elongase polypeptide, wherein said mutant delta-9 elongase polypeptide comprises SEQ ID NO:59.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2011
From: BOSTICK, MICHAEL W.; HE, HONGXIAN; LI, YOUGEN; ZHU, QUINN QUN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 027059/0744 →